Charles Peters

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi request reprint Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
    John E Wagner
    Blood and Marrow Transplant Program of the Department of Pediatrics, University of Minnesota Cancer Center and School of Medicine, Minneapolis 55455, USA
    Blood 100:1611-8. 2002
  2. ncbi request reprint Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
    Charles Peters
    Department of Pediatrics, University of Minnesota, Minneapolis, USA
    Blood 104:881-8. 2004
  3. ncbi request reprint Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation
    Kendra J Bjoraker
    Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
    J Dev Behav Pediatr 27:290-6. 2006
  4. ncbi request reprint Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders
    Sandhya Kharbanda
    University of Minnesota Cancer Center and Department of Pediatrics, Division of Pediatric Hematology Oncology and Blood and Marrow Transplant, Minneapolis, 55455, USA
    Biol Blood Marrow Transplant 12:430-7. 2006
  5. pmc Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells
    Chendong Pan
    Associate Professor of Medicine, University of Minnesota Medical School, Hematology Oncology Section 111E, VA Medical Center, One Veterans Dr, Minneapolis, MN 55417
    Blood 106:1956-64. 2005
  6. ncbi request reprint Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases
    Tracey A O'Brien
    Pediatric Hematology Oncology and Blood and Marrow Transplant Program, Medical School, University of Minnesota, Minneapolis, MN, USA
    Br J Haematol 127:67-75. 2004
  7. doi request reprint Predictive factors for vision loss after hematopoietic cell transplant for X-linked adrenoleukodystrophy
    Adam Gess
    Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J AAPOS 12:273-6. 2008
  8. doi request reprint Mucopolysaccharidosis I: management and treatment guidelines
    Joseph Muenzer
    Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA
    Pediatrics 123:19-29. 2009
  9. ncbi request reprint Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome
    Satkiran S Grewal
    Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Genet Med 7:143-6. 2005
  10. ncbi request reprint Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation
    Satkiran S Grewal
    Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, USA
    J Pediatr 144:569-73. 2004

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
    John E Wagner
    Blood and Marrow Transplant Program of the Department of Pediatrics, University of Minnesota Cancer Center and School of Medicine, Minneapolis 55455, USA
    Blood 100:1611-8. 2002
    ..7 x 10(5) CD34(+) cells per kilogram of recipient's body weight. Therefore, graft selection should be based principally on CD34 cell dose when multiple UCB units exist with an HLA disparity of 2 or less...
  2. ncbi request reprint Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999
    Charles Peters
    Department of Pediatrics, University of Minnesota, Minneapolis, USA
    Blood 104:881-8. 2004
    ..In this first comprehensive report of the international HCT experience for X-ALD, we conclude that boys with early-stage disease benefit from HCT, whereas boys with advanced disease may be candidates for experimental therapies...
  3. ncbi request reprint Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation
    Kendra J Bjoraker
    Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
    J Dev Behav Pediatr 27:290-6. 2006
    ..Although cognitive and orthopedic problems as well as medical complications limit adaptive ability, identifying these problems early allow beneficial targeted interventions...
  4. ncbi request reprint Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders
    Sandhya Kharbanda
    University of Minnesota Cancer Center and Department of Pediatrics, Division of Pediatric Hematology Oncology and Blood and Marrow Transplant, Minneapolis, 55455, USA
    Biol Blood Marrow Transplant 12:430-7. 2006
    ..Larger studies will be required to further elucidate etiologic mechanisms and predictive factors...
  5. pmc Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells
    Chendong Pan
    Associate Professor of Medicine, University of Minnesota Medical School, Hematology Oncology Section 111E, VA Medical Center, One Veterans Dr, Minneapolis, MN 55417
    Blood 106:1956-64. 2005
    ..Similar mechanisms may operate in the pathogenesis of other diseases where structurally abnormal GAGs accumulate...
  6. ncbi request reprint Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases
    Tracey A O'Brien
    Pediatric Hematology Oncology and Blood and Marrow Transplant Program, Medical School, University of Minnesota, Minneapolis, MN, USA
    Br J Haematol 127:67-75. 2004
    ..Alternative treatment strategies were employed, with the majority of patients demonstrating disease refractory to traditional steroid therapy...
  7. doi request reprint Predictive factors for vision loss after hematopoietic cell transplant for X-linked adrenoleukodystrophy
    Adam Gess
    Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J AAPOS 12:273-6. 2008
    ..Visual dysfunction is a common component of the disease and may continue to progress in patients after HCT. This study was designed to determine prognostic factors predictive of vision loss after HCT...
  8. doi request reprint Mucopolysaccharidosis I: management and treatment guidelines
    Joseph Muenzer
    Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA
    Pediatrics 123:19-29. 2009
    ..The availability of hematopoietic stem cell transplantation and the recent introduction of enzyme replacement therapy for mucopolysaccharidosis I necessitate the establishment of system-specific management guidelines for this condition...
  9. ncbi request reprint Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome
    Satkiran S Grewal
    Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Genet Med 7:143-6. 2005
    ..However, morbidity and mortality associated with HSCT can limit its success. We describe the initial experience with combined use of enzyme replacement therapy (ERT, laronidase) and HSCT in Hurler syndrome...
  10. ncbi request reprint Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation
    Satkiran S Grewal
    Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, USA
    J Pediatr 144:569-73. 2004
    ..To study the efficacy of hematopoietic stem cell transplantation (HCT) for ameliorating the clinical manifestations of alpha-mannosidosis...
  11. ncbi request reprint Azacitidine pharmacokinetics in an adolescent patient with renal compromise
    Courtney F Tsao
    Department of Pharmacy, Division of Hematology Oncology, The Children s Mercy Hospital and Clinics, University of Missouri, Kansas City, MO 64108, USA
    J Pediatr Hematol Oncol 29:330-3. 2007
    ....
  12. ncbi request reprint Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study
    Asif Mahmood
    Kennedy Krieger Institute and Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
    Lancet Neurol 6:687-92. 2007
    ..We analysed survival of CCALD patients who had not received HCT and, in a subgroup with early cerebral disease, compared survival in those who underwent HCT with those who did not...
  13. ncbi request reprint Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation
    Paola Corti
    Clinica Pediatrica, Universita di Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    Br J Haematol 130:249-55. 2005
    ..Because of the unique graft manipulation, the pace of lymphocyte reconstitution was particularly slow, suggesting that these patients are at a significantly increased risk of infections for up to 2 years after HCT...